The Effects of Vasopressin on Systemic and Splanchnic Hemodynamics and Metabolism in Endotoxin Shock

Anesthesia and Analgesia

Volumn 97, Issue 6, 2003, Pages 1756-1763

  Martikainen, Tero J ^a   Tenhunen, Jyrki J ^a   Uusaro, Ari ^a   Ruokonen, Esko ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; NORADRENALIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BLOOD PRESSURE MONITORING; CARBON DIOXIDE TENSION; COLON; CONTROLLED STUDY; DELIVERY; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; FEMALE; HEART OUTPUT; HEPATIC ARTERY; HYPOTENSION; JEJUNUM; MEAN ARTERIAL PRESSURE; MICRODIALYSIS; NONHUMAN; OXYGEN CONSUMPTION; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RANDOMIZATION; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; STOMACH; SUPERIOR MESENTERIC ARTERY; SWINE; SYSTEMIC CIRCULATION; TONOMETER;

EID: 0344420385     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000087039.60041.2E     Document Type: Article

References (23)

1. Rangel-Frausto M, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995;273:117-23.
2. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000;26:S64-74.
3. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
4. Doig CJ, Sutherland LR, Sandham JD, et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 1998;158:444-51.
5. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-5.
6. Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999;47:699-703.
7. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-82.
8. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002;359:1209-10.
9. Varga C, Pavo I, Lamarque D, et al. Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat. Eur J Pharmacol 1998;352:257-61.
10. Hansen EF, Strandberg C, Hojgaard L, et al. Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs. J Hepatol 1999;30:503-10.
11. Tenhunen JJ, Kosunen H, Alhava E, et al. Intestinal luminal microdialysis: a new approach to assess gut mucosal ischemia. Anesthesiology 1999;91:1807-15.
12. Moller S, Hansen EF, Becker U, et al. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000;20:51-9.
13. Scharte M, Meyer J, Van Aken H, Bone HG. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001;29:1756-60.
14. Holmes CL, Walley KR, Chittock DR, et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001;27:1416-21.
15. Schiffer ER, Mentha G, Schwieger IM, Morel DR. Sequential changes in the splanchnic circulation during continuous endotoxin infusion in sedated sheep: evidence for a selective increase of hepatic artery blood flow and loss of the hepatic arterial buffer response. Acta Physiol Scand 1993;147:251-61.
16. Jakob SM, Tenhunen JJ, Heino A, et al. Splanchnic vasoregulation during mesenteric ischemia and reperfusion in pigs. Shock 2002;18:142-7.
17. Trager K, Radermacher P, Rieger KM, et al. Norepinephrine and nomega-monomethyl-L-arginine in porcine septic shock: effects on hepatic O2 exchange and energy balance. Am J Respir Crit Care Med 1999;159:1758-65.
18. Jenkins SA, Mooney B, Devitt P, et al. The effect of vasopressin on hepatic artery flow in the rat. Clin Exp Pharmacol Physiol 1984;11:521-6.
19. Simmons JT, Baum S, Sheehan BA, et al. The effect of vasopressin on hepatic arterial blood flow. Radiology 1977;124:637-40.
20. Bynum TE, Fara JW. Hepatic artery response to vasopressin. Am J Physiol 1980;239:G378-81.
21. Krarup N. Effects of histamine, vasopressin, and angiotensin II on hepatosplanchnic hemodynamics, liver function, and hepatic metabolism in cats. Acta Physiol Scand 1975;95:311-7.
22. Tenhunen JJ, Jakob S, Ruokonen E, Takala J. Jejunal luminal microdialysate lactate in cardiac tamponade: effect of low systemic blood flow on gut mucosa. Intensive Care Med 2002;28:953-62.
23. Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001;29:487-93.